Top

Published in:

01-11-2016 | Literatur kommentiert

Therapie des lokalisierten nodulären Lymphozyten-prädominanten Hodgkin-Lymphoms bei Kindern

Authors: PD Dr. med. Georg Mann, Prof. Dr.med. Wolfgang Holter

Published in: Strahlentherapie und Onkologie | Issue 11/2016

Auszug

Prospektive nichtrandomisierte Studie zur Prüfung, ob die exzellenten Ergebnisse bei Kindern und Jugendlichen mit nodulärem Lymphozyten-prädominanten Hodgkin-Lymphom (NLPHL) niedriger Stadien nach einer Therapiereduktion erhalten bleiben. …

Appel BE, Chen L, Buxton AB et al (2016) Minimal treatment of low-risk, pediatric lymphocyte-predominant Hodgkin Lymphoma: A report from the Children’s Oncology Group. J Clin Oncol 34:2372–2379CrossRefPubMed

Arber DA, Orazi A, Hasserjian R (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405CrossRefPubMed

Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D et al (2007) Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110:179–185CrossRefPubMed

Shankar A, Hall GW, Gorde-Grosjean S et al (2012) Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodularlymphocyte predominant Hodgkin’slymphoma – an Anglo-French collaborative report. Eur J Cancer 48:1700–1706CrossRefPubMed

Shankar AG, Kirkwood AA, Depani S et al (2016) Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents – a report from the United Kingdom’s Children’s Cancer and Leukaemia Study Group. Br J Haematol 173:421–431CrossRefPubMed

Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinicalcorrelation. Am J Surg Pathol 27:1346–1356CrossRefPubMed

Boudová L, Torlakovic E, Delabie J et al (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T‑cell/histiocyte-rich B‑cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin lymphoma and T‑cell/histiocyte-rich B‑cell lymphoma. Blood 102:3753–3758CrossRefPubMed

Hartmann S, Eichenauer DA, Plütschow A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report fromthe German Hodgkin Study Group (GHSG). Blood 122:4246–4252CrossRefPubMed

Schellong G, Pötter R, Brämswig J et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group. J Clin Oncol 17:3736–3744PubMed

10.

Dörffel W, Rühl U, Lüders H et al (2013) Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol 31:1562–1568CrossRefPubMed

11.

Mauz-Körholz C, Hasenclever D, Dörffel W et al (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680–3686CrossRefPubMed

12.

Advani RH, Horning SJ, Hoppe RT et al (2014) Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 32:912–918CrossRefPubMed

Title: Therapie des lokalisierten nodulären Lymphozyten-prädominanten Hodgkin-Lymphoms bei Kindern
Authors: PD Dr. med. Georg Mann
Prof. Dr.med. Wolfgang Holter
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 11/2016
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-016-1044-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Therapie des lokalisierten nodulären Lymphozyten-prädominanten Hodgkin-Lymphoms bei Kindern

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 11/2016

Reduction of cardiac and coronary artery doses in irradiation of left-sided breast cancer during inspiration breath hold

Prä- oder postoperative Strahlentherapie bei retroperitonealen Sarkomen unverzichtbar

Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma

Novel technique for high-precision stereotactic irradiation of mouse brains

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma

Verbessertes Überleben bei Patienten mit primär metastasiertem Prostatakarzinom